Cite
APA Citation
Helou, J., D'Alimonte, L., Quon, H., Deabreu, A., Commisso, K., Cheung, P., Chu, W., Mamedov, A., Davidson, M., Ravi, A., & Loblaw, A. (n.d.). stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?. Radiotherapy and oncology, 123(3), 478–482. http://access.bl.uk/ark:/81055/vdc_100047276786.0x000052